IDEXX Laboratories (NASDAQ:IDXX), founded in 1983 and headquartered in Westbrook, Maine, is a leading provider of diagnostic and information technology-based products and services for the animal health, water testing and dairy markets. Originally established to develop rapid diagnostic tests for companion animals, the company has expanded its portfolio through both innovation and strategic acquisitions. Over the decades, IDEXX has grown into a diversified life sciences company, leveraging proprietary technologies to deliver actionable insights to its customers.
In the animal health segment, IDEXX offers a comprehensive suite of in-clinic diagnostic instruments, consumables and digital imaging solutions. Key products include the SNAP® family of rapid immunoassays, Catalyst® chemistry analyzers, ProCyte® hematology systems and sophisticated imaging equipment that enable veterinarians to perform a wide range of tests—from routine blood panels and disease screening to advanced imaging for soft tissue and orthopedic evaluation. The company also provides practice management software and telehealth services designed to streamline clinic operations and enhance patient care.
Beyond veterinary diagnostics, IDEXX serves the water quality and dairy industries. Its water microbiology business offers reagents, instruments and data management tools to detect pathogens and monitor water safety in municipal, recreational and industrial settings. In the dairy sector, IDEXX supplies tests for mastitis detection, antibiotics screening and herd health monitoring, helping producers maintain milk quality and comply with regulatory standards. The company’s emphasis on rapid, accurate results supports public health initiatives and food safety programs worldwide.
With operations in more than 175 countries, IDEXX maintains a global network of R&D centers, manufacturing facilities and distribution channels. The company is led by President and Chief Executive Officer Jonathan W. Ayers, who has overseen continued investment in innovation, expanded service offerings and international growth since 2018. Under his leadership, IDEXX remains focused on delivering cutting-edge diagnostics and data-driven solutions that empower customers to make timely, informed decisions.
